Exagen Inc News - XGN

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Exagen Inc. to Participate in Upcoming March Conferences

SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune...

Amended Statement of Ownership (sc 13g/a)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A ...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange...

Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

SAN DIEGO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune...

Current Report Filing (8-k)

0001274737FALSE12/3100012747372023-01-232023-01-23UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune...

Current Report Filing (8-k)

0001274737FALSE00012747372023-01-092023-01-09UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...

Current Report Filing (8-k)

0001274737FALSE00012747372022-12-052022-12-05UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...

Quarterly Report (10-q)

000127473712-312022Q3FALSEP3Yhttp://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmo...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Exagen Inc (XGN)

Professional-Grade Tools, for Individual Investors.

XGN News

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Exagen Inc. to Participate in Upcoming March Conferences

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Statement of Changes in Beneficial Ownership (4)

Amended Statement of Ownership (sc 13g/a)

Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Current Report Filing (8-k)

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

Current Report Filing (8-k)

Current Report Filing (8-k)

Statement of Ownership (sc 13g)

Quarterly Report (10-q)

XGN Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Exagen Inc (XGN) News

Exagen Inc (XGN)

Professional-Grade Tools, for Individual Investors.

XGN News

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Exagen Inc. to Participate in Upcoming March Conferences

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Statement of Changes in Beneficial Ownership (4)

Amended Statement of Ownership (sc 13g/a)

Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Current Report Filing (8-k)

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

Current Report Filing (8-k)

Current Report Filing (8-k)

Statement of Ownership (sc 13g)

Quarterly Report (10-q)

XGN Discussion

Your Recent History